179 related articles for article (PubMed ID: 23762475)
1. Targeting poly (ADP-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells.
Huang H; Cao Y; Wei W; Liu W; Lu SY; Chen YB; Wang Y; Yan H; Wu YL
PLoS One; 2013; 8(6):e66130. PubMed ID: 23762475
[TBL] [Abstract][Full Text] [Related]
2. MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.
Xiang RF; Wang Y; Zhang N; Xu WB; Cao Y; Tong J; Li JM; Wu YL; Yan H
Cell Death Dis; 2017 May; 8(5):e2776. PubMed ID: 28492559
[TBL] [Abstract][Full Text] [Related]
3. Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells.
Li M; Yu X; Guo H; Sun L; Wang A; Liu Q; Wang X; Li J
Tumour Biol; 2014 Mar; 35(3):2461-71. PubMed ID: 24218335
[TBL] [Abstract][Full Text] [Related]
4. Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
Hong SH; Choi YH
Oncol Rep; 2012 Jan; 27(1):114-20. PubMed ID: 21901250
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in carcinoma cells.
Mitchell C; Park M; Eulitt P; Yang C; Yacoub A; Dent P
Mol Pharmacol; 2010 Nov; 78(5):909-17. PubMed ID: 20696794
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
[TBL] [Abstract][Full Text] [Related]
7. Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.
Patel AG; Flatten KS; Schneider PA; Dai NT; McDonald JS; Poirier GG; Kaufmann SH
J Biol Chem; 2012 Feb; 287(6):4198-210. PubMed ID: 22158865
[TBL] [Abstract][Full Text] [Related]
8. Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways.
Li Y; Tian X; Liu X; Gong P
Carcinogenesis; 2018 May; 39(5):700-707. PubMed ID: 29546393
[TBL] [Abstract][Full Text] [Related]
9. Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide.
Liu J; Zhang Y; Sun S; Zhang G; Jiang K; Sun P; Zhang Y; Yao B; Sui R; Chen Y; Guo X; Tang T; Shi J; Liang H; Piao H
Oncol Res; 2019 Mar; 27(4):475-486. PubMed ID: 29793559
[TBL] [Abstract][Full Text] [Related]
10. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
[TBL] [Abstract][Full Text] [Related]
11. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.
Gu C; Wang Y; Zhang L; Qiao L; Sun S; Shao M; Tang X; Ding P; Tang C; Cao Y; Zhou Y; Guo M; Wei R; Li N; Xiao Y; Duan J; Yang Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):11. PubMed ID: 34991674
[TBL] [Abstract][Full Text] [Related]
12. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation.
Xie CM; Chan WY; Yu S; Zhao J; Cheng CH
Free Radic Biol Med; 2011 Oct; 51(7):1365-75. PubMed ID: 21763418
[TBL] [Abstract][Full Text] [Related]
13. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
14. Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma.
Chornenkyy Y; Agnihotri S; Yu M; Buczkowicz P; Rakopoulos P; Golbourn B; Garzia L; Siddaway R; Leung S; Rutka JT; Taylor MD; Dirks PB; Hawkins C
Mol Cancer Ther; 2015 Nov; 14(11):2560-8. PubMed ID: 26351319
[TBL] [Abstract][Full Text] [Related]
15. Bufalin induces cell cycle arrest and apoptosis in gallbladder carcinoma cells.
Jiang L; Zhao MN; Liu TY; Wu XS; Weng H; Ding Q; Shu YJ; Bao RF; Li ML; Mu JS; Wu WG; Ding QC; Cao Y; Hu YP; Shen BY; Tan ZJ; Liu YB
Tumour Biol; 2014 Nov; 35(11):10931-41. PubMed ID: 25085580
[TBL] [Abstract][Full Text] [Related]
16. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
17. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of poly (ADP-ribose) polymerase 1 leads to change of hydroquinone cytotoxicity in TK6 cells.
Sha Y; Zhou W; Yang Z; Zhu X; Yang X; Li TD; Zhu D
Toxicol Mech Methods; 2015; 25(6):467-77. PubMed ID: 26335980
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair.
Tempka D; Tokarz P; Chmielewska K; Kluska M; Pietrzak J; Rygielska Ż; Virág L; Robaszkiewicz A
Redox Biol; 2018 May; 15():316-326. PubMed ID: 29306194
[TBL] [Abstract][Full Text] [Related]
20. PARP1 Val762Ala polymorphism reduces enzymatic activity.
Wang XG; Wang ZQ; Tong WM; Shen Y
Biochem Biophys Res Commun; 2007 Mar; 354(1):122-6. PubMed ID: 17214964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
